Parallel findings indicate that HRG supports specific populations of tumor-associated macrophages, playing a key role in NAFLD progression to HCC, indicating HRG as a promising prognostic marker and therapeutic target (Foglia et al., 2024). The gene discussed is HRG; the disease is hepatocellular carcinoma.